Showing 91-100 of 108 results for "".
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Sculptra Scores FDA Nod for Cheek Wrinkleshttps://modernaesthetics.com/news/sculptra-scores-fda-nod-for-cheeks/2473402/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen produ
- Aziyo Biologics, Sientra Partner to Distribute SimpliDerm Productshttps://modernaesthetics.com/news/aziyo-biologics-sientra-partner-to-distribute-simpliderm-product-line/2473379/Aziyo Biologics, Inc. and Sientra, Inc. are joining forces to expand the distribution of Aziyo’s SimpliDerm product line. Under the agreement terms, Aziyo will grant Sientra certain non-exclusive rights in the United States to market, sell, and distribute SimpliDerm fo
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- SkinMedica Launches Firm & Tone Lotion for Bodyhttps://modernaesthetics.com/news/skinmedica-launches-firm-tone-lotion-for-body/2473292/Allergan Aesthetics, an AbbVie company has launched SkinMedica® Firm & Tone Lotion for Body, the line’s first product formulated to prevent and address visible signs of body skin aging for a toned look. SkinMedica says it is clinically proven to diminish the look of crepey
- Aesthetics Biomedical Inc. Scores Third U.S. Patent for SoME Skincarehttps://modernaesthetics.com/news/aesthetics-biomedical-inc-scores-third-us-patent-for-some-skincare/2473277/Aesthetics Biomedical Inc. scored its third U.S. patent for “biological preserving composition and methods of use” for its SoME skincare product line. The patent covers topical compositions for combining biologics with skincare preserving the exclusivity of SoME Skincar
- Revance News: FDA Accepts BLA Resubmission for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-news-fda-accepts-bla-resubmission-for-daxibotulinumtoxina/2473223/The U.S. Food and Drug Administration (FDA) accepted Revance’s Biologics License Application (BLA) resubmission for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The FDA designated the BLA as a Class 2 resubmission, which has a six-mont
- Happy 20th Birthday Botox Cosmetic!https://modernaesthetics.com/news/happy-20th-birthday-botox-cosmetic/2473218/Allergan Aesthetics’ BOTOX Cosmetic (onabotulinumtoxinA) turns 20 on April 15, 2022. This date marks 20 years since the U.S. Food and Drug Administration (FDA) first approved the product to temporarily improve the look of moderate to severe glabellar lines, located between th